Skip to content

Evaluation of Clinical Efficacy of Pneumonia Qingjie Recipe in Treating Community-Acquired Pneumonia (Non-Severe) with Phlegm-Heat Stagnation of Lung

Evaluation of Clinical Efficacy of Pneumonia Qingjie Recipe in Treating Community-Acquired Pneumonia (Non-Severe) with Phlegm-Heat Stagnation of Lung

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048275
Enrollment
Unknown
Registered
2021-07-05
Start date
2021-07-01
Completion date
Unknown
Last updated
2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Community acquired pneumonia (CAP)

Interventions

Sponsors

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for community-acquired pneumonia (non-severe); 2. Those who meet the CAP low and intermediate risk groups; 3. Comply with the standard of TCM syndrome differentiation of phlegm-heat obstructing the lung; 4. Aged 18 to 65 years, gender is not limited; 5. The onset time is less than 72 hours and no antibiotic treatment is used; 6. Agree and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. History of structural lung disease, diabetes, liver and kidney dysfunction and other underlying diseases; 2. Combined with serious heart, brain, lung, liver, kidney, blood system diseases and mental diseases and other basic diseases, such as acute heart failure, acute cerebral hemorrhage, viral hepatitis, hemophilia, etc.; 3. Patients with immunodeficiency or taking immunosuppressants or glucocorticoids within the past 3 months; 4. Other therapeutic drugs such as antiviral drugs, traditional Chinese medicine, etc. have been used within 48 hours of seeing a doctor; 5. Pregnant and lactating patients; 6. Allergic constitution, such as those who are allergic to more than two kinds of drugs or food, those who are known to be allergic to the ingredients of this drug and cephalosporin antibiotics.

Design outcomes

Primary

MeasureTime frame
Inflammation-related indicators;TCM syndrome integral;

Secondary

MeasureTime frame
Clinical pulmonary infection (CPIS) score;Time to reach initial treatment effective;Laboratory indexes;Electrocardiogram;Chest CT;

Countries

China

Contacts

Public ContactFang Hong

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

15000297742@163.com+86 18917763022

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026